Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other high-dividend stocks under $10. Investors often favor dividend stocks for their long-term ...

Viatris (VTRS, Financials) will pay up to $335 million in annual installments over nine years to settle opioid-related claims from U.S. states, local governments, and tribal entities, the company ...

Glancy Prongay & Murray LLP reminds investors of the upcoming June 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ...

Viatris to pay up to $335 million over nine years to settle opioid claims nationwide. The company has accrued $270 million for potential resolution, noted in its 2024 10-K filing. Pelosi’s ...

With a market cap of $14.8 billion, Viatris Inc. (VTRS) is a global pharmaceutical company formed in 2020 through the merger of Mylan and Upjohn, a former Pfizer division. Headquartered in ...

Viatris to Pay up to $335 Million to Resolve Opioid-Related Claims (Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve ...

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other oversold stocks to buy in 2025 amid inflation fears. The stock market continues to face ...

Shares of Viatris Inc. VTRS shed 3.07% to $9.15 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to 5,667.56 and ...

SAN DIEGO, April 4, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Viatris Inc. (NASDAQ ...